thymoquinone has been researched along with poloxin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, T; Hofmann, M; Krämer, A; Kreis, NN; Reindl, W; Sanhaji, M; Strebhardt, K; Yuan, J; Zimmer, B | 1 |
| Shin, SB; Woo, SU; Yim, H | 1 |
| Archambault, V; Beautrait, A; Duchaine, J; Futter, M; Guiral, S; Lavallée, JF; Marinier, A; Normandin, K | 1 |
| Archambault, V; Normandin, K | 1 |
4 other study(ies) available for thymoquinone and poloxin
| Article | Year |
|---|---|
Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo.
Topics: Animals; Apoptosis; Benzoates; Benzoquinones; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Centrosome; Chromosomes, Human; Humans; M Phase Cell Cycle Checkpoints; Mice; Neoplasms; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Quinones; Xenograft Model Antitumor Assays | 2011 |
Differential Cellular Effects of Plk1 Inhibitors Targeting the ATP-binding Domain or Polo-box Domain.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Benzimidazoles; Benzoates; Benzoquinones; Binding Sites; Catalytic Domain; Cell Cycle Proteins; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Design; Female; G2 Phase Cell Cycle Checkpoints; HeLa Cells; Humans; Inhibitory Concentration 50; Mitosis; Molecular Targeted Therapy; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Pteridines; Quinones; S Phase Cell Cycle Checkpoints; Signal Transduction; Thiophenes; Time Factors; Uterine Cervical Neoplasms | 2015 |
Identification of Polo-like kinase 1 interaction inhibitors using a novel cell-based assay.
Topics: Alkylating Agents; Benzoates; Benzoquinones; Bioluminescence Resonance Energy Transfer Techniques; Cell Cycle Proteins; HEK293 Cells; High-Throughput Screening Assays; Humans; Polo-Like Kinase 1; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Quinones; Small Molecule Libraries; Structure-Activity Relationship | 2016 |
Several inhibitors of the Plk1 Polo-Box Domain turn out to be non-specific protein alkylators.
Topics: Alkylation; Antineoplastic Agents; Benzoates; Benzoquinones; Cell Cycle Proteins; Glycine; Humans; Mitosis; Neoplasms; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Quinones; Sulfones | 2017 |